Literature DB >> 11780632

A 250-nucleotide UA-rich element in the 3' untranslated region of Xenopus laevis Vg1 mRNA represses translation both in vivo and in vitro.

L J Otero1, A Devaux, N Standart.   

Abstract

Xenopus laevis Vgl mRNA undergoes both localization and translational control during oogenesis. Vg1 protein does not appear until late stage IV, after localization is complete. To determine whether Vg1 translation is regulated by cytoplasmic polyadenylation, the RACE-PAT method was used. Vg1 mRNA has a constant poly(A) tail throughout oogenesis, precluding a role for cytoplasmic polyadenylation. To identify cis-acting elements involved in Vg1 translational control, the Vg1 3' UTR was inserted downstream of the luciferase ORF and in vitro transcribed, adenylated mRNA injected into stage III or stage VI oocytes. The Vg1 3' UTR repressed luciferase translation in both stages. Deletion analysis of the Vg1 3' UTR revealed that a 250-nt UA-rich fragment, the Vg1 translational element or VTE, which lies 118 nt downstream of the Vg1 localization element, could repress translation as well as the full-length Vg1 3' UTR. Poly(A)-dependent translation is not necessary for repression as nonadenylated mRNAs are also repressed, but cap-dependent translation is required as introduction of the classical swine fever virus IRES upstream of the luciferase coding region prevents repression by the VTE. Repression by the Vg1 3' UTR has been reproduced in Xenopus oocyte in vitro translation extracts, which show a 10-25-fold synergy between the cap and poly(A) tail. A number of proteins UV crosslink to the VTE including FRGY2 and proteins of 36, 42, 45, and 60 kDa. The abundance of p42, p45, and p60 is strikingly higher in stages I-III than in later stages, consistent with a possible role for these proteins in Vg1 translational control.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11780632      PMCID: PMC1370215     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  66 in total

Review 1.  Polarizing genetic information in the egg: RNA localization in the frog oocyte.

Authors:  M L King; Y Zhou; M Bubunenko
Journal:  Bioessays       Date:  1999-07       Impact factor: 4.345

2.  Cytoplasmic polyadenylation elements mediate masking and unmasking of cyclin B1 mRNA.

Authors:  C H de Moor; J D Richter
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 3.  Analysis of translational activity of extracts derived from oocytes and eggs of Xenopus laevis.

Authors:  V M Pain; T D Patrick; R Cox; S J Morley
Journal:  Methods Mol Biol       Date:  1998

4.  The clam 3' UTR masking element-binding protein p82 is a member of the CPEB family.

Authors:  J Walker; N Minshall; L Hake; J Richter; N Standart
Journal:  RNA       Date:  1999-01       Impact factor: 4.942

Review 5.  Control of translation initiation in animals.

Authors:  N K Gray; M Wickens
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

6.  The Nanos gradient in Drosophila embryos is generated by translational regulation.

Authors:  A Dahanukar; R P Wharton
Journal:  Genes Dev       Date:  1996-10-15       Impact factor: 11.361

7.  smaug protein represses translation of unlocalized nanos mRNA in the Drosophila embryo.

Authors:  C A Smibert; J E Wilson; K Kerr; P M Macdonald
Journal:  Genes Dev       Date:  1996-10-15       Impact factor: 11.361

8.  Complex formation between stage-specific oocyte factors and a Xenopus mRNA localization element.

Authors:  K L Mowry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 9.  RNA localization in development.

Authors:  A Bashirullah; R L Cooperstock; H D Lipshitz
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

10.  Role for mRNA localization in translational activation but not spatial restriction of nanos RNA.

Authors:  S E Bergsten; E R Gavis
Journal:  Development       Date:  1999-02       Impact factor: 6.868

View more
  13 in total

1.  Organizing the oocyte: RNA localization meets phase separation.

Authors:  Sarah E Cabral; Kimberly L Mowry
Journal:  Curr Top Dev Biol       Date:  2020-03-09       Impact factor: 4.897

Review 2.  Regulation of gene expression by stop codon recoding: selenocysteine.

Authors:  Paul R Copeland
Journal:  Gene       Date:  2003-07-17       Impact factor: 3.688

3.  General translational repression by activators of mRNA decapping.

Authors:  Jeff Coller; Roy Parker
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

4.  Spatially restricted translation of the xCR1 mRNA in Xenopus embryos.

Authors:  Yan Zhang; Kara D Forinash; Jered McGivern; Brian Fritz; Karel Dorey; Michael D Sheets
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

Review 5.  Controlling the Messenger: Regulated Translation of Maternal mRNAs in Xenopus laevis Development.

Authors:  Michael D Sheets; Catherine A Fox; Megan E Dowdle; Susanne Imboden Blaser; Andy Chung; Sookhee Park
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  The Xenopus ELAV protein ElrB represses Vg1 mRNA translation during oogenesis.

Authors:  Lucy J Colegrove-Otero; Agathe Devaux; Nancy Standart
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Preparation of a highly active cell-free translation system from immature Xenopus laevis oocytes.

Authors:  Catherine A Pratt; Kimberly L Mowry
Journal:  Methods       Date:  2010-02-01       Impact factor: 3.608

8.  Spatial regulation of translation through RNA localization.

Authors:  Graydon B Gonsalvez; Roy M Long
Journal:  F1000 Biol Rep       Date:  2012-08-01

9.  A manganese-dependent ribozyme in the 3'-untranslated region of Xenopus Vg1 mRNA.

Authors:  Nikolay G Kolev; Emilia I Hartland; Paul W Huber
Journal:  Nucleic Acids Res       Date:  2008-08-27       Impact factor: 16.971

10.  Selective pharmacological targeting of a DEAD box RNA helicase.

Authors:  Lisa Lindqvist; Monika Oberer; Mikhail Reibarkh; Regina Cencic; Marie-Eve Bordeleau; Emily Vogt; Assen Marintchev; Junichi Tanaka; Francois Fagotto; Michael Altmann; Gerhard Wagner; Jerry Pelletier
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.